www.kinled.com Open in urlscan Pro
34.149.87.45  Public Scan

Form analysis
0 forms found in the DOM

Text Content

top of page


OUR FOCUS

Kinled is a company which retains the assets of the Anglo-Austrian Aisher Family
through direct investments in innovative businesses in the Life Science and
Digital Technology sectors.

To learn more about our history, Click Here



Today, in life sciences, we have a laser-focus on innovation in the biomedical
technology, medical devices, bio pharmaceuticals, and healthcare services
sectors, which represents over 50% of our portfolio.

In digital technologies, we invest in SaaS-enabled networks and marketplaces,
where technology can democratize markets and provide consumers with greater
choice of services.

In fintech, we invest in companies that use technology to challenge the
traditional established institutions by providing superior service in embedded
payment platforms, insurance, real estate, lending and banking.



Kinled Holding is a Partner in four dedicated life science investment companies
based in Boston, Vienna, Gibraltar and Zurich, with combined Assets under
Management of $250M, and two specific digital technology Funds based in Vienna
and London with combined Assets under Management of €225M.

View our portfolio
View Portfolio By Industry >
Browse our portfolio by industry

View Portfolio By Location >
Browse our portfolio by location




OUR PORTFOLIO


A PRIVATELY OWNED HOLDING COMPANY WITH INVESTMENTS IN THE LIFE SCIENCES, DIGITAL
AND FINANCIAL TECHNOLOGY SECTORS. 

Learn More
View our portfolio


☰


FOSTERING INNOVATION

Kinled Holding and the Aisher Family have long believed in fostering academic
projects to become commercial businesses.

We have proudly funded early stage businesses in Austria and Switzerland that
originated in Universities such as Zürich, Bern, Fribourg, Geneva, Lausanne,
Graz, Innsbruck, and Vienna and have a substantial track record of developing
successful international businesses from within with the Swiss Federal Institute
of Technology and the University of Vienna. 

 

In the United States, we funded early stage businesses that originated in
Universities from Boston, Cambridge, Harvard, Houston, Massachusetts Institute
of Technology, Michigan, New York, Northeastern, San Diego, San Francisco, to
Stanford. In Europe Kinled portfolio firms were created with technology from
Universities such as Aix-Marseille, Amsterdam, Barcelona, Helsinki, Linköping,
London, Paris, Pecs, and Utrecht.

 

To learn more about some of successful exits, Click Here > 

Co-investment opportunities


OPPORTUNITIES

Co-investment opportunities

Kinled has created a number of mechanisms to allow co-investment from
sophisticated and qualified family-offices who wish to support us in developing
academic/scientific projects and nascent technologies.



Today all our investments are processed through three independently-managed
incubator/accelerators that Kinled is a founder shareholder in, and one EU
regulated fund that we manage, as well as a special opportunity investment
company that  co-invests with Concentric, a UK regulated technology fund.



Cebina The Central European Biotech Incubator & Accelerator at the University of
Vienna’s Campus Biotech, supports innovative biotechnology companies focused on
inflammation, neurology and ageing. 



Mountain Labs is Switzerland’s first full service search lab, start-up incubator
and technology investment facilitator, sourcing new investment opportunities and
bridging the gap between entrepreneurs and capital finance.



Danube Labs brings together CEBINA’s strength in scientific innovation and
entrepreneurship, with Evotec’s industry-leading drug discovery and development
expertise to accelerate academic life science research projects with a focus on
Central and Eastern European Universities and Research Institutes.



Cebina Bridge Capital is an EU AIFMD regulated fund whose objective is to
provide absolute return to Participating Shareholders by investing in
pharmaceutical drug discovery and biotech projects in Central and Eastern
Europe.

© Kinled Holding ltd. All Rights Reserved.  |  VIEW OUR DISCLAIMER

 * Home
 * Contact
 * Medtech
 * Biotech
 * FinTech
 * DigiTech
 * Other
 * England
 * USA
 * Switzerland
 * Austria
 * Location
 * Disclaimer
 * Europe
 * ROW
 * Exits
 * Exits
 * Co-Invest
 * Biotech Key Holdings
 * Medtech Key Holdings
 * Fintech Key Holdings
 * Digitech Key Holdings
 * Investment Qualification


☰
bottom of page